Document Detail


A national program for lowering high blood cholesterol.
MedLine Citation:
PMID:  3287928     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The National Institutes of Health have begun a new National Cholesterol Education Program. This program is modeled on the 15-year-old National High Blood Pressure Education Program, which has played a major role in improving the detection and treatment of hypertension in this country. Similar success can be predicted for the National Cholesterol Education Program, given the similarity between these two risk factors--hypertension and cholesterol--in (1) the accumulated scientific evidence for the benefit of intervention, (2) the availability of classification and treatment guidelines, and (3) the approach to professional and public health education programs. The new National Cholesterol Education Program guidelines recommend that all adults undergo a blood cholesterol measurement at least once every 5 years. Patients with a level greater than 200 mg/dl (confirmed by a second measurement) should be advised to adopt a step 1 fat-controlled diet. Patients with a cholesterol level greater than 240 mg/dl are candidates for intensive treatment with step 2 diet and sometimes drugs, as are those in the 200 to 240 mg/dl range who are at especially high risk because they already have coronary heart disease or two other risk factors. However, drugs for lowering blood cholesterol levels should be used only when the indication has been confirmed by measurements of low-density lipoprotein cholesterol and as a supplement to continuing the dietary treatment.
Authors:
S B Hulley
Related Documents :
6732988 - Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in ...
17996508 - Prevalence of low high-density lipoprotein cholesterol in patients with documented coro...
11074738 - The andro project: physiological and hormonal influences of androstenedione supplementa...
9465548 - The sex differences in cord-blood cholesterol and fatty-acid levels among japanese fetu...
9875068 - Dietary fish oil and digestible protein modify susceptibility to lipid peroxidation in ...
16239128 - The study of the effects of diet on metabolism and nutrition (stedman) weight loss proj...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  158     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1988 Jun 
Date Detail:
Created Date:  1988-07-14     Completed Date:  1988-07-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1561-7     Citation Subset:  AIM; IM    
Affiliation:
Clinical Epidemiology Program, Institute for Health Policy Studies, San Francisco, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antilipemic Agents / therapeutic use
Cholesterol, LDL / blood
Coronary Disease / blood*,  mortality,  prevention & control,  therapy
Diet
Female
Health Education*
Humans
Hypercholesterolemia / therapy*
Hypertension / complications,  therapy
Male
National Institutes of Health (U.S.)
Risk Factors
United States
Chemical
Reg. No./Substance:
0/Antilipemic Agents; 0/Cholesterol, LDL

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  XK aprosencephaly and anencephaly in sibs.
Next Document:  Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglyceri...